about
Human CD100, a novel leukocyte semaphorin that promotes B-cell aggregation and differentiationT cell receptor (TCR) interacting molecule (TRIM), a novel disulfide-linked dimer associated with the TCR-CD3-zeta complex, recruits intracellular signaling proteins to the plasma membraneEngagement of CD160 receptor by HLA-C is a triggering mechanism used by circulating natural killer (NK) cells to mediate cytotoxicity.BY55 monoclonal antibody delineates within human cord blood and bone marrow lymphocytes distinct cell subsets mediating cytotoxic activityUse of a variable alpha region to create a functional T-cell receptor delta chainThe Uterine Immune Profile May Help Women With Repeated Unexplained Embryo Implantation Failure After In Vitro FertilizationRegulatory T-cells in pregnancy: historical perspective, state of the art, and burning questionsTargeting the Tumor Microenvironment: The Protumor Effects of IL-17 Related to Cancer TypeBY55/CD160 acts as a co-receptor in TCR signal transduction of a human circulating cytotoxic effector T lymphocyte subset lacking CD28 expressionFunctional characterization of neurotensin receptors in human cutaneous T cell lymphoma malignant lymphocytesSemaphorin CD100 from activated T lymphocytes induces process extension collapse in oligodendrocytes and death of immature neural cellsKIR3DL2: a new step for the management of patients with Sezary syndromeIncreased surface expression of a newly identified 150-kDa dimer early after human T lymphocyte activationIdentification of a novel CD160+ CD4+ T-lymphocyte subset in the skin: a possible role for CD160 in skin inflammationA soluble form of the MHC class I-specific CD160 receptor is released from human activated NK lymphocytes and inhibits cell-mediated cytotoxicityMUC1-ARF-A Novel MUC1 Protein That Resides in the Nucleus and Is Expressed by Alternate Reading Frame Translation of MUC1 mRNA.Active chronic sarcoidosis is characterized by increased transitional blood B cells, increased IL-10-producing regulatory B cells and high BAFF levels.Regulatory T cells differentially modulate the maturation and apoptosis of human CD8+ T-cell subsets.Lymphocyte-derived interleukin-17A adds another brick in the wall of inflammation-induced breast carcinogenesis.Detection of membrane-bound HLA-G translated products with a specific monoclonal antibodyCD101 expression by Langerhans cell histiocytosis cells.CD39/adenosine pathway is involved in AIDS progressionTWEAK affects keratinocyte G2/M growth arrest and induces apoptosis through the translocation of the AIF protein to the nucleus.The receptors regulating natural cytotoxic effector functions.Granulocyte-Colony Stimulating Factor related pathways tested on an endometrial ex-vivo modelSezary syndrome cells unlike normal circulating T lymphocytes fail to migrate following engagement of NT1 receptor.CD antigens 2001.CD molecules 2005: human cell differentiation molecules.CD101 is expressed by skin dendritic cells. Role in T-lymphocyte activation.Generation of monoclonal antibodies to a human natural killer clone. Characterization of two natural killer-associated antigens, NKH1A and NKH2, expressed on subsets of large granular lymphocytes.Human endothelial cells generate Th17 and regulatory T cells under inflammatory conditions.Seminal plasma peptides may determine maternal immune response that alters success or failure of pregnancy in the abortion-prone CBAxDBA/2 model.Identification of cell surface molecules characterizing human cutaneous T-cell lymphomas.Extranodal NK/T-cell lymphoma: toward the identification of clinical molecular targetsA novel antiangiogenic and vascular normalization therapy targeted against human CD160 receptor.T-plastin expression downstream to the calcineurin/NFAT pathway is involved in keratinocyte migration.IFN-α and CD46 stimulation are associated with active lupus and skew natural T regulatory cell differentiation to type 1 regulatory T (Tr1) cellsImmunopathogenesis of cutaneous T-cell lymphomas.VEGF kinoid vaccine, a therapeutic approach against tumor angiogenesis and metastases.CD39: A complementary target to immune checkpoints to counteract tumor-mediated immunosuppression.
P50
Q24314914-E5A0142C-F6A4-4140-8E5E-98A2E10571DBQ24319819-E37E0AC5-B1E1-4F40-88B5-3060DBF29E31Q24544012-68BAF99B-9A6E-47E2-9E21-BD7EA3B09205Q24563723-6D87B69C-CCDE-454D-A6FD-21B325A08431Q24652334-A26F9037-A671-44FE-90FB-4800B88DAA86Q26771571-865F9EBA-CB81-4921-B72B-E26C9CD9BE3AQ26998637-735EACFE-85EE-4A99-AC74-A75561E2AB6EQ28066522-DACE6678-E9BB-4BF2-BF8B-FFF1CC7A7736Q28215924-70C2856B-0FD9-431C-8D24-548111AB8E31Q28216598-F9F00FCE-4459-4D3A-9CE7-C5E958543F6DQ28237271-80D29F6C-55F5-4267-9464-9A6F426C2CDAQ28262709-EBE5D9A5-F8BA-443B-BAE8-6F35D7470E93Q28276903-0A6BB3C6-4466-4F29-9925-7B6E27E9A8D8Q28283054-6DC192EA-7435-4277-914C-0C23A2E2EB0EQ28284183-968034CA-76A5-4E71-A369-4DD722C415E9Q30008839-8A061210-D827-4A1E-9383-17773DCEEDA7Q31087724-9A93452D-9F53-45B2-B95D-9DA2AFB4C295Q33611828-8932D5C5-6273-4DF4-B306-BFD1AB512451Q33776130-39BE2045-DFF1-4BA3-9AD4-DF43AD81FBEBQ33832555-76E4FB60-4F81-4DB9-93F4-AC314C1E6C8AQ33891447-98DA73CB-E1D3-4F20-815B-AA231747D1EEQ33959186-64E431AB-1AE3-45D9-A085-F0BEF0A4975FQ34206359-A32F76AB-7FBF-487A-A7D8-618FA1E459E2Q34248583-0D98E9B0-448B-40B3-9018-3A83F52F03EBQ34281982-9B014814-FFB3-408B-9132-2397AC7B2C0AQ34298520-8BF59B7B-72B0-44ED-A7B2-DA1B48BDE78DQ34348909-EB0CBDD3-1BF3-4988-9448-366DC9C2450CQ34434101-742FF2D1-4604-4980-BA92-E5A072AC7B28Q34448316-7C9E2331-B619-4A7B-9F72-8F3389363A6FQ34536541-456FCBD8-FAC3-471F-9907-4C056116040CQ34583004-541CF9FD-D618-4018-B706-E099E1464960Q34736113-057EF737-CD6E-49F7-A8EF-09F7C36A290BQ34769861-A37C5FEC-ACAB-41F8-8285-50702D2CB9BCQ34898306-B719E307-C958-4708-BAF4-81FA412088BBQ34973743-7B7DA594-1C53-428A-8E3D-3AFFDA724DB8Q35256001-07E9E86D-E06E-4478-88DB-4CB6516AF901Q35571367-A149C422-84E9-4E50-A590-9FDB5B46ED6FQ35622801-A74CD806-C063-4336-99FB-0EC4B38665F5Q35635564-2AF2AB10-15CD-4D97-BEA0-4ADF4D482033Q35798953-426129A3-4328-46A7-A9B0-400C2C25C9CA
P50
description
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Armand Bensussan
@ast
Armand Bensussan
@en
Armand Bensussan
@es
Armand Bensussan
@nl
Armand Bensussan
@sl
type
label
Armand Bensussan
@ast
Armand Bensussan
@en
Armand Bensussan
@es
Armand Bensussan
@nl
Armand Bensussan
@sl
prefLabel
Armand Bensussan
@ast
Armand Bensussan
@en
Armand Bensussan
@es
Armand Bensussan
@nl
Armand Bensussan
@sl
P214
P106
P21
P214
P31
P496
0000-0002-0409-2497
P7859
viaf-12376090